St. Jude Children's Research Hospital

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1962-01-01

Employees: -

Market Cap: -

Website: http://www.stjude.org/

Clinical Trials

Evaluating the Clinical Utility of the T-SPOT.CMV Assay for the Prediction of CMV Reactivation Among Pediatric Patients Undergoing Hematopoietic Cell Transplant

Terminated

Conditions: CMV

Interventions: Diagnostic Test: T-SPOT®.CMV Test

First Posted Date: 2018-06-27

Last Posted Date: 2019-06-11

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 11

Registration Number: NCT03570411

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

18F-Fluorodopamine PET Studies of Neuroblastoma and Pheochromocytoma

Early Phase 1

Recruiting

Conditions: Pheochromocytoma
Neuroblastoma

Interventions: Drug: 18F-DA

First Posted Date: 2018-05-30

Last Posted Date: 2024-07-03

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 20

Registration Number: NCT03541720

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Treatment With Combination Chemotherapy for Relapsed or Refractory Acute Lymphoblastic Leukemia

Phase 1

Terminated

Conditions: Acute Lymphoblastic Leukemia With Failed Remission
Acute Lymphoblastic Leukemia, in Relapse

Interventions: Drug: Palbociclib Oral Capsule
Drug: Intrathecal Triple Therapy
Drug: Dexamethasone
Drug: Bortezomib
Drug: Dasatinib
Drug: Doxorubicin
Drug: Ruxolitinib

First Posted Date: 2018-05-03

Last Posted Date: 2020-09-01

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 12

Registration Number: NCT03515200

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors

Phase 1

Completed

Conditions: Anaplastic Astrocytoma
Anaplastic Ependymoma
Anaplastic Ganglioglioma
Anaplastic Meningioma
Anaplastic Oligodendroglioma
Pleomorphic Xanthoastrocytoma, Anaplastic
Atypical Teratoid/Rhabdoid Tumor
Brain Cancer
Brain Tumor
Central Nervous System Neoplasms

Interventions: Drug: ribociclib
Drug: Gemcitabine
Drug: trametinib
Drug: sonidegib
Biological: filgrastim

First Posted Date: 2018-02-15

Last Posted Date: 2024-05-31

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 68

Registration Number: NCT03434262

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Predictors and Outcomes in Patients With Sickle Cell Disease

Active, not recruiting

Conditions: Sickle Cell Disease

First Posted Date: 2018-02-13

Last Posted Date: 2024-04-04

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 94

Registration Number: NCT03431935

Locations: 🇺🇸
Methodist Adult Comprehensive Sickle Cell Center, Memphis, Tennessee, United States
🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Obstructive Sleep Apnea in Survivors of Hodgkin Lymphoma Treated With Thoracic Radiation

Active, not recruiting

Conditions: Obstructive Sleep Apnea
Hodgkin Lymphoma

First Posted Date: 2017-12-04

Last Posted Date: 2024-08-09

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 434

Registration Number: NCT03361020

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Components of Social Functioning in Survivors of Pediatric Brain Tumors

Active, not recruiting

Conditions: Brain Tumor, Pediatric
Medulloblastoma, Pediatric

First Posted Date: 2017-12-04

Last Posted Date: 2024-06-13

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 80

Registration Number: NCT03361033

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease

Not Applicable

Recruiting

Conditions: Sickle Cell Disease
Vaso-occlusive Crisis

Interventions: Other: Virtual Reality Therapy

First Posted Date: 2017-11-27

Last Posted Date: 2024-10-08

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 76

Registration Number: NCT03353584

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
🇺🇸
Methodist Comprehensive Sickle Cell Center, Memphis, Tennessee, United States

Re-Aiming at Hydroxyurea Adherence for Sickle Cell With mHealth

Completed

Conditions: Sickle Cell Disease

First Posted Date: 2017-11-17

Last Posted Date: 2019-12-11

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 100

Registration Number: NCT03344900

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
🇺🇸
Baptist Memorial Hospital, Baptist Clinical Research Institute, Memphis, Tennessee, United States

Examination of Sleep and Family Functioning in Pediatric Craniopharyngioma Patients

Completed

Conditions: Craniopharyngioma

First Posted Date: 2017-11-06

Last Posted Date: 2019-03-08

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 41

Registration Number: NCT03330080

Locations: 🇺🇸
St . Jude Children's Research Hospital, Memphis, Tennessee, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy